Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-10 08:32 am Purchase |
2021-12-31 | 13G | Ovid Therapeutics Inc. OVID |
The Vanguard Group | 3,442,618 5.060% |
3,442,618 (New Position) |
Filing History |
| 2021-07-12 08:29 am Sale |
2021-06-30 | 13G | Ovid Therapeutics Inc. OVID |
BLACKROCK INC BLK |
1,202,730 1.800% |
-2,209,003 (-64.75%) |
Filing History |
| 2021-04-29 4:48 pm Purchase |
2021-04-20 | 13G | Ovid Therapeutics Inc. OVID |
Stonepine Capital Management, LLC | 3,500,000 5.300% |
3,500,000 (New Position) |
Filing History |
| 2021-04-15 4:11 pm Purchase |
2021-04-13 | 13G | Ovid Therapeutics Inc. OVID |
BIOTECHNOLOGY VALUE FUND L P | 6,631,051 10.100% |
2,109,000 (+46.64%) |
Filing History |
| 2021-03-09 2:31 pm Unchanged |
2021-03-04 | 13G | Ovid Therapeutics Inc. OVID |
EcoR1 Capital Fund L.P. | 6,082,200 9.600% |
0 (Unchanged) |
Filing History |
| 2021-03-09 1:19 pm Purchase |
2020-03-04 | 13G | Ovid Therapeutics Inc. OVID |
EcoR1 Capital Fund L.P. | 6,082,200 9.600% |
6,082,200 (New Position) |
Filing History |
| 2021-02-17 3:13 pm Sale |
2020-12-31 | 13G | Ovid Therapeutics Inc. OVID |
Consonance Capital Management LP | 0 0.000% |
-6,058,505 (Position Closed) |
Filing History |
| 2021-02-16 4:39 pm Sale |
2020-12-31 | 13G | Ovid Therapeutics Inc. OVID |
During Matthew | 4,020,794 6.300% |
-964,811 (-19.35%) |
Filing History |
| 2021-02-16 4:37 pm Purchase |
2020-12-31 | 13G | Ovid Therapeutics Inc. OVID |
LEVIN JEREMY M | 6,092,270 9.600% |
369,337 (+6.45%) |
Filing History |
| 2021-02-16 2:22 pm Purchase |
2020-12-31 | 13G | Ovid Therapeutics Inc. OVID |
Consonance Capital Management LP | 6,058,505 11.000% |
3,169,617 (+109.72%) |
Filing History |
| 2021-02-12 4:18 pm Sale |
2020-12-31 | 13G | Ovid Therapeutics Inc. OVID |
BIOTECHNOLOGY VALUE FUND L P | 4,522,051 6.900% |
-733,250 (-13.95%) |
Filing History |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | Ovid Therapeutics Inc. OVID |
BLACKROCK INC BLK |
3,411,733 5.400% |
2,756,291 (+420.52%) |
Filing History |
| 2021-01-05 3:12 pm Purchase |
2020-12-31 | 13G | Ovid Therapeutics Inc. OVID |
SINGER JAMES R | 3,000,000 4.700% |
150,000 (+5.26%) |
Filing History |
| 2020-05-27 11:59 am Sale |
2020-03-11 | 13D | Ovid Therapeutics Inc. OVID |
TLS Advisors LLC | 2,489,415 4.550% |
-477,450 (-16.09%) |
Filing History |
| 2020-05-13 2:54 pm Purchase |
2020-03-11 | 13D | Ovid Therapeutics Inc. OVID |
TradeLink Holdings LLC | 2,489,415 4.550% |
2,489,415 (New Position) |
Filing History |